BFC Planning’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.84K Hold
20
– – ﹤0.01% 2791
2026
Q2
$2.73K Buy
20
+11
+122% +$1.35K ﹤0.01% 2900
2026
Q1
$1.06K Hold
9
– – ﹤0.01% 2733
2025
Q4
$1.48K Hold
9
– – ﹤0.01% 2706
2025
Q3
$1.2K Sell
9
-3
-25% -$364 ﹤0.01% 2591
2025
Q2
$1.49K Sell
12
-12
-50% -$1.53K ﹤0.01% 2372
2025
Q1
$3.05K Hold
24
– – ﹤0.01% 2188
2024
Q4
$3.46K Sell
24
-10
-29% -$1.43K ﹤0.01% 2118
2024
Q3
$5.06K Buy
+34
New +$4.88K ﹤0.01% 2006

Other funds holding RGEN

BFC Planning's RGEN Position: Q3 2026 in Review

BFC Planning held its Repligen (RGEN) position steady in Q3 2026 at 20 shares worth $3.84K. The position accounts for ﹤0.01% of the portfolio, ranked #2791.

BFC Planning first reported a position in RGEN in Q3 2024 and has held it in 9 quarters since. The position peaked at $5.06K in Q3 2024. 403 funds tracked by Wall St. Rank hold RGEN as of Q3 2026.

  • BFC Planning held 20 shares of Repligen worth $3.84K as of Q3 2026.
  • BFC Planning left its Repligen share count unchanged in Q3 2026.
  • Repligen made up ﹤0.01% of BFC Planning's portfolio in Q3 2026, its #2791 holding.
  • BFC Planning first reported a position in Repligen in Q3 2024 and has held it in 9 quarters since.
  • BFC Planning's Repligen position peaked at $5.06K in Q3 2024.
  • 403 funds tracked by Wall St. Rank held Repligen as of Q3 2026.

Based on BFC Planning's 13F filing for Q3 2026, filed 13 Nov 2026.